SE442110B - 4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur - Google Patents

4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur

Info

Publication number
SE442110B
SE442110B SE8107101A SE8107101A SE442110B SE 442110 B SE442110 B SE 442110B SE 8107101 A SE8107101 A SE 8107101A SE 8107101 A SE8107101 A SE 8107101A SE 442110 B SE442110 B SE 442110B
Authority
SE
Sweden
Prior art keywords
acid
reaction
salts
sodium
picolylthio
Prior art date
Application number
SE8107101A
Other languages
English (en)
Swedish (sv)
Other versions
SE8107101L (sv
Inventor
J G Lombardino
C A Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8107101L publication Critical patent/SE8107101L/xx
Publication of SE442110B publication Critical patent/SE442110B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8107101A 1981-06-26 1981-11-27 4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur SE442110B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,242 US4371696A (en) 1980-07-14 1981-06-26 Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof

Publications (2)

Publication Number Publication Date
SE8107101L SE8107101L (sv) 1982-12-27
SE442110B true SE442110B (sv) 1985-12-02

Family

ID=23055809

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107101A SE442110B (sv) 1981-06-26 1981-11-27 4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur

Country Status (22)

Country Link
US (1) US4371696A (fr)
JP (1) JPS58916A (fr)
AU (1) AU528433B2 (fr)
BE (1) BE890374R (fr)
CH (1) CH648483A5 (fr)
DE (1) DE3215648A1 (fr)
FR (1) FR2508904B2 (fr)
GB (1) GB2100600B (fr)
GR (1) GR75753B (fr)
HK (1) HK67087A (fr)
IE (1) IE51727B1 (fr)
IL (1) IL63699A0 (fr)
IT (1) IT1200569B (fr)
KE (1) KE3458A (fr)
LU (1) LU83827A1 (fr)
MY (1) MY8500351A (fr)
NL (1) NL8105744A (fr)
NZ (1) NZ198215A (fr)
PH (1) PH17742A (fr)
SE (1) SE442110B (fr)
SG (1) SG56084G (fr)
ZA (1) ZA821139B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6179685U (fr) * 1984-10-26 1986-05-27
JPS61207304A (ja) * 1985-03-11 1986-09-13 Toyo Soda Mfg Co Ltd 農園芸用殺菌剤
JPH0445817Y2 (fr) * 1988-09-09 1992-10-28
US5610198A (en) * 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
GB1434271A (en) * 1972-09-28 1976-05-05 Squibb & Sons Inc Cephalosporins
US4246263A (en) * 1979-10-15 1981-01-20 Pfizer Inc. Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Also Published As

Publication number Publication date
JPS58916A (ja) 1983-01-06
IT8219162A0 (it) 1982-01-18
FR2508904A2 (fr) 1983-01-07
GB2100600B (en) 1983-09-14
US4371696A (en) 1983-02-01
KE3458A (en) 1984-10-12
IE812748L (en) 1982-12-26
ZA821139B (en) 1983-01-26
MY8500351A (en) 1985-12-31
GB2100600A (en) 1983-01-06
SE8107101L (sv) 1982-12-27
IL63699A0 (en) 1981-11-30
HK67087A (en) 1987-09-25
GR75753B (fr) 1984-08-02
LU83827A1 (fr) 1982-05-07
AU528433B2 (en) 1983-04-28
FR2508904B2 (fr) 1985-11-29
IT1200569B (it) 1989-01-27
CH648483A5 (fr) 1985-03-29
NL8105744A (nl) 1983-01-17
DE3215648A1 (de) 1983-01-13
NZ198215A (en) 1984-07-06
PH17742A (en) 1984-11-27
SG56084G (en) 1985-03-08
IE51727B1 (en) 1987-03-04
BE890374R (fr) 1982-03-16

Similar Documents

Publication Publication Date Title
RU2125051C1 (ru) Производные дифенила, производное фенилпиперазина и способ лечения
KR910002583B1 (ko) 피페라진 유도체 또는 이의 염, 이의 제조방법 및 활성 성분으로서 이를 함유하는 약제학적 조성물
KR910000639B1 (ko) 4-시아노피리다진의 제조방법
BG65967B1 (bg) Тиенодибензоазуленови съединения като инхибитори на туморен некрозен фактор
SE433748B (sv) Forfarande for framstellning av estrar av (6r, 7r-3-karbamoyloximetyl-7-((z)-2-(fur-2-yl)-2-metoxiimionacetamido)-cef-3-em-4-karbonsyra
JPS62230767A (ja) アセトアミド誘導体、その製造方法およびその医薬への応用
JPS63290868A (ja) ジケトピペラジン誘導体およびその塩類
CN101481323A (zh) 苯并环庚烯类衍生物、其制备方法及医药用途
US4535084A (en) Certain 4-(2-hydroxyethylthiomethyl)pyridines and derivatives thereof having immunoregulatory activity
SE442110B (sv) 4-pikolyltioettiksyror och alkylestrar derav till anvendning for reglering av immunforsvaret hos deggdjur
US4246263A (en) Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions
JPS6231719B2 (fr)
EP0025109A2 (fr) Dérivés de 1-benzoxépin-5(2H)-ones et leurs sels, et procédés pour leur préparation
US5332743A (en) Benzyl and benzhydryl alcohols
EP0090275B1 (fr) Isoxazole (5,4-b) pyridines
US4006184A (en) 1- OR 2-[2-Hydroxy-3-amino-propoxy]-9,10-dihydro-9,10-ethano-anthracenes and their salts
WO1994008956A1 (fr) ANALOGUE DE N-t-BUTYLANILINE ET REDUCTEUR DU TAUX LIPIDIQUE LE RENFERMANT
JPH0440348B2 (fr)
CA1164862A (fr) Derives de l'acide indole-acetique, procede de production et composes pharmaceutiques les contenant
US4500535A (en) Method of regulating the immune response with pyridine derivatives
CN116478050B (zh) 一种手性芳基丙酸衍生物及其药物组合物和用途
DE3726633A1 (de) Neue 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JP3902801B2 (ja) ビフェニル誘導体
KR850001039B1 (ko) 알로파노일 피페라진 화합물의 제조방법
EP0153746B1 (fr) Dérivés 3-amino-2-hydroxypropyl de pyrimidine-4-one

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8107101-1

Effective date: 19900706

Format of ref document f/p: F